These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 17349281)

  • 1. [IL-23R, a novel susceptibility gene for inflammatory bowel disease].
    Peyrin-Biroulet L; Parmentier-Decrucq E; Branche J; Desreumaux P
    Med Sci (Paris); 2007 Mar; 23(3):250-2. PubMed ID: 17349281
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunopathogenesis of inflammatory bowel disease: current concepts.
    Bamias G; Cominelli F
    Curr Opin Gastroenterol; 2007 Jul; 23(4):365-9. PubMed ID: 17545770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TGF-beta is necessary for induction of IL-23R and Th17 differentiation by IL-6 and IL-23.
    Morishima N; Mizoguchi I; Takeda K; Mizuguchi J; Yoshimoto T
    Biochem Biophys Res Commun; 2009 Aug; 386(1):105-10. PubMed ID: 19501566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biomedicine. Puzzling out the pains in the gut.
    Marx J
    Science; 2007 Jan; 315(5808):33-5. PubMed ID: 17204619
    [No Abstract]   [Full Text] [Related]  

  • 5. [Recent advances in the immunopathogenesis of inflammatory bowel diseases].
    Watanabe T; Chiba T
    Nihon Rinsho; 2012 Feb; 70 Suppl 1():10-5. PubMed ID: 23126060
    [No Abstract]   [Full Text] [Related]  

  • 6. TGF-beta and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain T(H)-17 cell-mediated pathology.
    McGeachy MJ; Bak-Jensen KS; Chen Y; Tato CM; Blumenschein W; McClanahan T; Cua DJ
    Nat Immunol; 2007 Dec; 8(12):1390-7. PubMed ID: 17994024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significance of interleukin-1beta and interleukin-1 receptor antagonist genetic polymorphism in inflammatory bowel diseases.
    Heresbach D; Alizadeh M; Dabadie A; Le Berre N; Colombel JF; Yaouanq J; Bretagne JF; Semana G
    Am J Gastroenterol; 1997 Jul; 92(7):1164-9. PubMed ID: 9219791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-1 and IL-23 induce innate IL-17 production from gammadelta T cells, amplifying Th17 responses and autoimmunity.
    Sutton CE; Lalor SJ; Sweeney CM; Brereton CF; Lavelle EC; Mills KH
    Immunity; 2009 Aug; 31(2):331-41. PubMed ID: 19682929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukins 1beta and 6 but not transforming growth factor-beta are essential for the differentiation of interleukin 17-producing human T helper cells.
    Acosta-Rodriguez EV; Napolitani G; Lanzavecchia A; Sallusto F
    Nat Immunol; 2007 Sep; 8(9):942-9. PubMed ID: 17676045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IFN-beta inhibits human Th17 cell differentiation.
    Ramgolam VS; Sha Y; Jin J; Zhang X; Markovic-Plese S
    J Immunol; 2009 Oct; 183(8):5418-27. PubMed ID: 19783688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukins 27 and 6 induce STAT3-mediated T cell production of interleukin 10.
    Stumhofer JS; Silver JS; Laurence A; Porrett PM; Harris TH; Turka LA; Ernst M; Saris CJ; O'Shea JJ; Hunter CA
    Nat Immunol; 2007 Dec; 8(12):1363-71. PubMed ID: 17994025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Replication of an association between IL23R gene polymorphism with inflammatory bowel disease.
    Oliver J; Rueda B; López-Nevot MA; Gómez-García M; Martín J
    Clin Gastroenterol Hepatol; 2007 Aug; 5(8):977-81, 981.e1-2. PubMed ID: 17678845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence of the presence of T helper type 17 cells in chronic lesions of human periodontal disease.
    Cardoso CR; Garlet GP; Crippa GE; Rosa AL; Júnior WM; Rossi MA; Silva JS
    Oral Microbiol Immunol; 2009 Feb; 24(1):1-6. PubMed ID: 19121062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of cytokine gene polymorphisms in determining disease susceptibility and phenotype in inflammatory bowel disease.
    Cantor MJ; Nickerson P; Bernstein CN
    Am J Gastroenterol; 2005 May; 100(5):1134-42. PubMed ID: 15842590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-23 and IL-12 responses in activated human T cells retrovirally transduced with IL-23 receptor variants.
    de Paus RA; van de Wetering D; van Dissel JT; van de Vosse E
    Mol Immunol; 2008 Sep; 45(15):3889-95. PubMed ID: 18675459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [TH17 differentiation, a complex process in mouse and man].
    Soumelis V; Volpe E
    Med Sci (Paris); 2008 Nov; 24(11):925-7. PubMed ID: 19038094
    [No Abstract]   [Full Text] [Related]  

  • 17. Association of interleukin-23 receptor variants with ankylosing spondylitis.
    Rahman P; Inman RD; Gladman DD; Reeve JP; Peddle L; Maksymowych WP
    Arthritis Rheum; 2008 Apr; 58(4):1020-5. PubMed ID: 18383363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A critical function for transforming growth factor-beta, interleukin 23 and proinflammatory cytokines in driving and modulating human T(H)-17 responses.
    Volpe E; Servant N; Zollinger R; Bogiatzi SI; Hupé P; Barillot E; Soumelis V
    Nat Immunol; 2008 Jun; 9(6):650-7. PubMed ID: 18454150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammatory bowel disease. I. Genetic epidemiology.
    Yang H; Taylor KD; Rotter JI
    Mol Genet Metab; 2001; 74(1-2):1-21. PubMed ID: 11592800
    [No Abstract]   [Full Text] [Related]  

  • 20. The interleukin 23 receptor gene in multiple sclerosis: a case-control study.
    Roos IM; Kockum I; Hillert J
    J Neuroimmunol; 2008 Feb; 194(1-2):173-80. PubMed ID: 18164077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.